The evolutionarily well-conserved transcription factor RFX7 was identified in 2008 [18], and it was only recently that RFX7 was identified as a tumor suppressor when a larger number of whole-genome sequencing analyses of cancer samples became available [2–4]. Here, RFX7 is linked to neoplasm.